Читать книгу Anti-Aging Therapeutics Volume XIV - A4M American Academy - Страница 42

For saliva, blood spot, and venous bioavailable testosterone the goal is mid to high-end of normal range or until clinical effects are achieved and an adequate duration of benefits are seen. If adverse reactions are absent and negative metabolites are not elevated, clinical response trumps testosterone levels. If levels are above the normal range no reduction in dose is needed if there are no adverse reactions and metabolites (E2 and DHT) are in range.